NCT05018416Phase 2Completed

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Study sponsor: Prokidney

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-20Actual
Enrollment · participants53Actual
Source updated2026-03-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview